1.41
price up icon7.63%   0.10
after-market Handel nachbörslich: 1.47 0.06 +4.26%
loading
Schlusskurs vom Vortag:
$1.31
Offen:
$1.36
24-Stunden-Volumen:
698.81K
Relative Volume:
2.20
Marktkapitalisierung:
$68.11M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-90.97M
KGV:
-0.7485
EPS:
-1.8837
Netto-Cashflow:
$-32.83M
1W Leistung:
+17.50%
1M Leistung:
-12.42%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$1.36
$1.53
1-Wochen-Bereich:
Value
$1.19
$1.53
52-Wochen-Spanne:
Value
$1.16
$2.0901

Filana Therapeutics Inc Stock (FLNA) Company Profile

Name
Firmenname
Filana Therapeutics Inc
Name
Telefon
512-501-2444
Name
Adresse
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN
Name
Mitarbeiter
20
Name
Twitter
Name
Nächster Verdiensttermin
2026-05-14
Name
Neueste SEC-Einreichungen
Name
FLNA's Discussions on Twitter

Compare FLNA vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
FLNA icon
FLNA
Filana Therapeutics Inc
1.41 63.28M 0 -90.97M -32.83M -1.8837
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
435.93 110.28B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
634.62 66.98B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
808.43 50.15B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
295.50 39.71B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
154.89 32.22B 742.00K -1.37B -1.07B -7.0731

Filana Therapeutics Inc Stock (FLNA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-26 Herabstufung H.C. Wainwright Buy → Neutral
2024-10-08 Hochstufung H.C. Wainwright Neutral → Buy
2024-07-01 Herabstufung H.C. Wainwright Buy → Neutral
2022-11-16 Herabstufung B. Riley Securities Buy → Neutral
2021-07-15 Herabstufung Cantor Fitzgerald Overweight → Neutral
2021-07-07 Bestätigt Maxim Group Buy
2021-04-27 Eingeleitet B. Riley Securities Buy
2021-02-16 Bestätigt H.C. Wainwright Buy
2020-10-23 Eingeleitet Cantor Fitzgerald Overweight
2020-09-23 Hochstufung H.C. Wainwright Neutral → Buy
2020-05-18 Herabstufung H.C. Wainwright Buy → Neutral
2020-05-15 Herabstufung Maxim Group Buy → Hold
2020-01-10 Bestätigt Maxim Group Buy
Alle ansehen

Filana Therapeutics Inc Aktie (FLNA) Neueste Nachrichten

pulisher
May 23, 2026

Filana Therapeutics (FLNA) Posts Modest Gains Amid Broader Biotech ResilienceExpert Breakout Alerts - Newser

May 23, 2026
pulisher
May 23, 2026

FLNA Should I Buy - Intellectia AI

May 23, 2026
pulisher
May 21, 2026

Filana Therapeutics (FLNA) Stock: Up +0.80%, Key Resistance at $1.32 2026-05-21Community Trade Ideas - Newser

May 21, 2026
pulisher
May 21, 2026

FLNA Price Today: Filana Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC

May 21, 2026
pulisher
May 21, 2026

FLNA Stock Price, Quote & Chart | FILANA THERAPEUTICS INC (NASDAQ:FLNA) - ChartMill

May 21, 2026
pulisher
May 12, 2026

MSN Money - MSN

May 12, 2026
pulisher
May 07, 2026

Filana Therapeutics 1Q Loss/Shr 21c >FLNA - Moomoo

May 07, 2026
pulisher
May 07, 2026

Filana Therapeutics (NASDAQ: FLNA) trims Q1 2026 loss, pivots simufilam to TSC epilepsy - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Filana Therapeutics Releases Q1 2026 Financial Results and Business Update on May 7, 2026 - geneonline.com

May 07, 2026
pulisher
May 07, 2026

Filana Therapeutics Reports Q1 2026 Financial Results and Business Update - The Manila Times

May 07, 2026
pulisher
May 07, 2026

Cost cuts shrink Filana Therapeutics (NASDAQ: FLNA) Q1 2026 net loss - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Biotech with $86.6M cash says FDA hold keeps epilepsy trial on hold - Stock Titan

May 07, 2026
pulisher
May 05, 2026

Cassava Sciences | 8-K: Current report - Moomoo

May 05, 2026
pulisher
May 05, 2026

At a Madrid epilepsy meeting, Filana detailed why it’s testing simufilam - Stock Titan

May 05, 2026
pulisher
May 05, 2026

Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII - GlobeNewswire

May 05, 2026
pulisher
May 05, 2026

MSN - MSN

May 05, 2026
pulisher
Apr 28, 2026

[ARS] FILANA THERAPEUTICS, INC. SEC Filing - Stock Titan

Apr 28, 2026
pulisher
Apr 28, 2026

Filana Therapeutics (FLNA) details 2026 meeting and equity plan vote - Stock Titan

Apr 28, 2026
pulisher
Apr 28, 2026

Filana Therapeutics (FLNA) director O’Donnell to leave board after 2026 meeting - Stock Titan

Apr 28, 2026
pulisher
Apr 27, 2026

How does Filana Therapeutics (FLNA) make money? (Market Focus) 2026-04-27Senior Analyst Forecasts - newser.com

Apr 27, 2026
pulisher
Apr 24, 2026

Cassava Sciences (FLNA) Stock Price, News & Analysis $FLNA - MarketBeat

Apr 24, 2026
pulisher
Apr 21, 2026

FLNA Filana Therapeutics posts narrower than expected Q3 2025 loss, shares edge higher in today’s trading.Trade Idea Marketplace - Newser

Apr 21, 2026
pulisher
Apr 21, 2026

Is Filana Therapeutics (FLNA) stock appealing for long-term investors (Slight Rise) 2026-04-20Continuation Pattern - Xã Châu Thành

Apr 21, 2026

Finanzdaten der Filana Therapeutics Inc-Aktie (FLNA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$29.66
price down icon 0.98%
$92.25
price up icon 0.12%
$108.87
price up icon 2.48%
$53.86
price down icon 1.17%
ONC ONC
$302.44
price down icon 2.52%
$154.89
price up icon 2.20%
Kapitalisierung:     |  Volumen (24h):